Support and Resources for Patients Taking Jakafi®

If you would like to keep up to date with news and information about Jakafi, there are three ways:

Register now for information and support resources


IncyteCARES: Connecting eligible* patients taking Jakafi® with ongoing support and resources

IncyteCARES is a personalized patient support program for people taking Jakafi. Guided by oncology certified nurses, IncyteCARES can connect eligible patients to a variety of resources. An IncyteCARES nurse partners with you as your single point of contact to connect you with:

Insurance Assistance
Help understanding your insurance coverage for Jakafi and, if needed, provide guidance with appealing insurance denials or coverage restrictions

Delivery Coordination
Help coordinating delivery of Jakafi to either your home or to your Healthcare Professional's office

Patient Assistance Options*

  • Copay/Coinsurance Assistance
    • Pay as little as $25 per month if you have commercial or private insurance
  • The Patient Assistance Program (PAP)
    • If you have no prescription coverage for Jakafi, you may be provided it free of charge

Temporary Access* for Insurance Coverage Delays
If you experience an insurance coverage delay, you may be able to receive a free supply of Jakafi

Ongoing Education and Support
An IncyteCARES oncology certified nurse supports you with information, tools, and resources

Connection to Support and Resources
IncyteCARES can identify and refer you to other resources, such as independent nonprofit organizations (INOs) or foundations. If you’re not eligible for assistance through IncyteCARES or need support beyond what IncyteCARES can provide, you may be eligible for outside assistance.

Referrals to Independent third-party organizations that may be able to assist with:

  • Arranging transportation to and from medical appointments
  • Travel cost assistance
  • Copay/coinsurance assistance
  • Emotional and educational support

INOs may also be able to provide the following services to patients and caregivers:

  • Supportive counseling for emotional, social, and practical concerns
  • Information about support groups and referrals to local services at no cost

Visit www.IncyteCARES.com to learn more.

*Terms and conditions apply.

Some foundations or organizations may receive or have received donations from Incyte Corporation.

Have questions? Connect with an oncology certified nurse, from IncyteCARES

Phone: 1-855-4-Jakafi (1-855-452-5234), Monday through Friday 8 am–8 pm, ET

Email your question now.

IncyteCARES may be able to help you with copay/coinsurance assistance for your treatment with Jakafi®

If you have been prescribed Jakafi and have private or commercial prescription insurance, you may be eligible to receive Jakafi for as little as $25 per month, subject to monthly and annual limits.‡§

If you have been prescribed Jakafi, IncyteCARES may be able to assist you in meeting your copay/coinsurance.

Criteria for Copay/Coinsurance Assistance:

To qualify, you must meet the following criteria:

  • Have commercial or private insurance (eg, BCBS, Aetna). Patients insured through Medicare,
    Medicaid, and TRICARE are not eligible. Please call 1-855-4-Jakafi for more information
  • Be a resident of the United States or Puerto Rico
  • Have a valid prescription for Jakafi for an FDA-approved use
  • Disclose the use of the card to your insurers

How to enroll:

After you receive your prescription for Jakafi from your Healthcare Professional:

  • Call IncyteCARES at 1-855-4-Jakafi (1-855-452-5234)
  • Answer a few simple questions to activate your copay/coinsurance card
  • Contact the pharmacy that is providing Jakafi and give them your card Group, Bin, and Member numbers to receive copay/coinsurance assistance for your prescription

Visit the IncyteCARES website to learn more.

Amount of savings for the purchase of Jakafi will not exceed $25,000 per year. Program benefits are subject to a monthly limit. Uninsured, cash-paying patients are not eligible. Not valid for patients covered under state or federally funded healthcare programs. Valid prescription for Jakafi for an FDA-approved indication is required. Please see full criteria for eligibility at www.IncyteCARES.com or call IncyteCARES.

§Patients insured through Medicare, Medicaid, and TRICARE are not eligible.

Pharmacies: Call 1-855-799-1295 to activate card.

Resources

Understanding Polycythemia Vera (PV): A guide for patients and caregivers

This guide was written to help people with PV and their loved ones better understand the disease and its treatment. It also provides information to help you prepare to talk with your Healthcare Professional about whether treatment with Jakafi may be right for you.

Download the guide

Understanding Myelofibrosis

This guide was written to help people with MF and their loved ones better understand intermediate and high-risk MF and its treatment. It also provides information to help you prepare to discuss with your Healthcare Professional whether treatment with Jakafi may be right for you.

Download the guide

Additional organizations

For more information, click on each link.

Ask a question

If you have questions about Jakafi or Incyte, please contact us via IncyteCARES at
1-855-4-Jakafi (1-855-452-5234).

Share this page:

Expand +

Indications and Usage

Jakafi is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.

Jakafi is also used to treat certain types of myelofibrosis.

Important Safety Information

Jakafi can cause serious side effects, including:

Low blood counts: Jakafi® (ruxolitinib) may cause your platelet, red blood cell, or white blood cell counts to be lowered. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will perform blood tests to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.

Infection: You may be at risk for developing a serious infection during treatment with Jakafi. Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters.

Skin cancers: Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Tell your healthcare provider if you develop any new or changing skin lesions.

Increases in cholesterol: You may have changes in your blood cholesterol levels. Your healthcare provider will do blood tests to check your cholesterol levels during your treatment with Jakafi.

The most common side effects of Jakafi include: low platelet count, low red blood cell counts, bruising, dizziness, headache.

These are not all the possible side effects of Jakafi. Ask your pharmacist or healthcare provider for more information. Tell your healthcare provider about any side effect that bothers you or that does not go away.

Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had tuberculosis (TB) or have been in close contact with someone who has TB, have or had hepatitis B, have or had liver or kidney problems, are on dialysis, had skin cancer, or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change your dose or stop taking Jakafi without first talking to your healthcare provider. Do not drink grapefruit juice while on Jakafi.

Women should not take Jakafi while pregnant or planning to become pregnant, or if breast-feeding.

Please see the Full Prescribing Information, which includes a more complete discussion of the risks associated with Jakafi.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also report side effects to Incyte Medical Information at 1-855-463-3463.
 
IMPORTANT SAFETY INFORMATION
 
INDICATIONS AND USAGE

Jakafi is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.

Jakafi is also used to treat certain types of myelofibrosis.

IMPORTANT SAFETY INFORMATION

Jakafi can cause serious side effects, including:

Low blood counts: Jakafi® (ruxolitinib) may cause your platelet, red blood cell, or white blood cell counts to be lowered. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will perform blood tests to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.

Infection: You may be at risk for developing a serious infection during treatment with Jakafi. Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters.

Skin cancers: Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Tell your healthcare provider if you develop any new or changing skin lesions.

Increases in cholesterol: You may have changes in your blood cholesterol levels. Your healthcare provider will do blood tests to check your cholesterol levels during your treatment with Jakafi.

The most common side effects of Jakafi include: low platelet count, low red blood cell counts, bruising, dizziness, headache.

These are not all the possible side effects of Jakafi. Ask your pharmacist or healthcare provider for more information. Tell your healthcare provider about any side effect that bothers you or that does not go away.

Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had tuberculosis (TB) or have been in close contact with someone who has TB, have or had hepatitis B, have or had liver or kidney problems, are on dialysis, had skin cancer, or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change your dose or stop taking Jakafi without first talking to your healthcare provider. Do not drink grapefruit juice while on Jakafi.

Women should not take Jakafi while pregnant or planning to become pregnant, or if breast-feeding.

Please see the Full Prescribing Information, which includes a more complete discussion of the risks associated with Jakafi.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also report side effects to Incyte Medical Information at 1-855-463-3463.

INDICATIONS AND USAGE

Jakafi is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.

Jakafi is also used to treat certain types of myelofibrosis.

IMPORTANT SAFETY INFORMATION

Jakafi can cause serious side effects, including:

Low blood counts: Jakafi® (ruxolitinib) may cause your platelet, red blood cell, or white blood cell counts to be lowered. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will perform blood tests to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.

Infection: You may be at risk for developing a serious infection during treatment with Jakafi. Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters.

Skin cancers: Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Tell your healthcare provider if you develop any new or changing skin lesions.

Increases in cholesterol: You may have changes in your blood cholesterol levels. Your healthcare provider will do blood tests to check your cholesterol levels during your treatment with Jakafi.

The most common side effects of Jakafi include: low platelet count, low red blood cell counts, bruising, dizziness, headache.

These are not all the possible side effects of Jakafi. Ask your pharmacist or healthcare provider for more information. Tell your healthcare provider about any side effect that bothers you or that does not go away.

Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had tuberculosis (TB) or have been in close contact with someone who has TB, have or had hepatitis B, have or had liver or kidney problems, are on dialysis, had skin cancer, or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change your dose or stop taking Jakafi without first talking to your healthcare provider. Do not drink grapefruit juice while on Jakafi.

Women should not take Jakafi while pregnant or planning to become pregnant, or if breast-feeding.

Please see the Full Prescribing Information, which includes a more complete discussion of the risks associated with Jakafi.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also report side effects to Incyte Medical Information at 1-855-463-3463.